Skip to main content
OpenTrials
Completed

NCT Number: NCT04402684

Influenza Vaccination in Patients Living With HIV in the Northern Region

Anyone living with the Human Immunodeficiency Virus (HIV) has an indication for annual influenza vaccination. (Vaccination schedule and vaccination recommendations 2019). Influenza is a viral infection that has a significant impact on the health care system. However, vaccination coverage in France is still insufficient with regard to the objectives set at 75% by the WHO and the European Commission. For the 2019-2020 seasonal influenza vaccination campaign, flu vaccination by volunteer pharmacists has become possible throughout the country. Studies that have estimated vaccination coverage among HIV-positive populations are rare and show very low rates.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CH Tourcoing

Tourcoing, France

About this study

Cross-sectional study via a self-questionnaire given to all HIV-infected patients coming for a scheduled consultation as part of their HIV follow-up in the spring of 2020. Non-opposition letter given to the patient. Collection of data a posteriori from the medical file recorded in the eNadis patient file.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any adult person living with HIV presenting for a follow-up consultation in the spring of 2020
  • People who do not read French may participate if they wish with the help of a medical or paramedical staff member.
  • Patient did not object

Exclusion criteria

  • Minor patients
  • Major under guardianship, curatorship, protected person

Treatment and study plan

Primary outcomes

  1. questionnaire influenza vaccine coverage

    Time frame: through study completion, an average of 1 year

    The objective of this questionnaire is to estimate the influenza vaccine coverage among PVVIH followed at the Tourcoing Hospital Center.

Secondary outcomes

  1. modalities of influenza vaccination

    Time frame: through study completion, an average of 1 year

    To identify the modalities of influenza vaccination when it is carried out

  2. the drivers and disincentives to influenza vaccination

    Time frame: through study completion, an average of 1 year

    Estimate from patient reports the drivers and disincentives to influenza vaccination in a specific risk population.

Sponsors and collaborators

Lead sponsor

Tourcoing Hospital

Other

Registry information

Official study title

Influenza Vaccination in Patients Living With HIV in the Northern Region: An Observational Monocentre Study of Blankets, Modalities, Drivers and Brakes

Acronym: VACCIGRIPPE

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
May 27, 2020
Registry last updated
Jan 26, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.